Increased expression of NT5DC2 (5’-nucleotidase domain-containing 2) has been linked to immunological infiltration and is a predictor of a poor outcome in patients with HCC, with possible uses in clinical stratification [31–34]. This evidence concerns the gene NT5DC2 and hepatocellular carcinoma.